Fear of Opioids for Postsurgical Cancer Patients
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to understand how individuals recovering from cancer surgery feel about using opioid medications after hospital discharge. Participants will engage in a 20-minute virtual meeting one week after discharge to discuss their experiences and complete questionnaires. The trial suits adults who underwent cancer surgery, stayed in the hospital for at least a day, and received a prescription for opioid painkillers upon discharge. Participants must be comfortable with virtual meetings and able to communicate in English. As an unphased trial, this study offers participants the chance to contribute to valuable research that could enhance post-surgery care for future patients.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It focuses on your feelings about prescribed opioid medication after surgery.
What prior data suggests that the Opiophobia Assessment is safe?
Research shows that the Opiophobia Assessment involves completing questionnaires about patients' feelings on using opioids after surgery. No direct evidence exists on the safety of the assessment itself, as it aims to understand patients' attitudes rather than introduce a new drug or treatment. Participants answer questions during a brief online visit, which is generally safe because it excludes physical procedures or medications.
Since the trial does not involve experimental drugs or procedures, no side effects are expected from the assessment itself. The focus is on communication and understanding, ensuring participants face no physical risks.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to address opiophobia in postsurgical adults with cancer using a virtual approach. Unlike traditional treatments that focus solely on medication management, this method involves a virtual visit to help patients manage their concerns about opioid use after surgery. By utilizing online questionnaires and direct interaction with the research team, the trial seeks to better understand and alleviate the fear of opioid use, potentially leading to improved pain management strategies.
What evidence suggests that the Opiophobia Assessment is effective for understanding fear of opioids in postsurgical cancer patients?
Research shows that many patients fear using opioids after surgery. In past studies, many patients expressed concerns about taking these pain medications, which can affect their pain management. This fear might lead them to avoid the medicine they need for relief. Effective pain management is crucial for healing and comfort. This trial will assess opiophobia in postsurgical cancer patients through virtual visits. By understanding this fear, healthcare providers can address these concerns and enhance patient care.13567
Who Is on the Research Team?
Eileen Hacker, PHD,RN
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Post-Discharge Assessment
Participants have a virtual visit about 7 days after discharge to complete questionnaires
Follow-up
Participants are monitored for barriers and fears related to opioid use after surgery
What Are the Treatments Tested in This Trial?
Interventions
- Opiophobia Assessment
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Participants that agree to take part in this study, partiicpants will have a virtual visit, via Zoom, about 7 days after you are discharged from the hospital. The visit will take about 20 minutes, and you will meet with a member of the research team to complete several questionnaires.
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Sigma Theta Tau International
Collaborator
Citations
Opioid-Free Anesthesia and Postoperative Outcomes in ...
We present a systematic review to evaluate the efficacy of OFA compared to OBA in the specific subset of cancer patients undergoing surgery.
2.
acsjournals.onlinelibrary.wiley.com
acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.70009The impact of opioid use associated with curative‐intent ...
NewPersOU has been reported at 10.4% among patients with a cancer diagnosis undergoing curative-intent surgery. Cancer survivors are at risk for ...
Opiophobia in Postsurgical Adults With Cancer
A way for patients with serious diseases or conditions who cannot participate in a clinical trial to gain access to a medical product that has not been approved ...
Opiophobia in Postsurgical Adults with Cancer
The purpose of this study is to explore the occurrence of opiophobia among postsurgical adults with cancer and hypothesized associations among opiophobia, ...
Opiophobia: Misinformation, Misconceptions ...
51% reported being treated for a new painful condition. 40% reported having a new surgery. 6% reported being treated for pain from the initial ...
The impact of opioid use associated with curative‐intent ...
Opioid exposure during cancer therapy may increase long‐term unsafe opioid prescribing. This study sought to determine the rates of ...
Management of cancer pain in adult patients
Pain is common in cancer patients, particularly in the advanced stage of disease when the prevalence is estimated to be more than 70%.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.